It is currently Sun Nov 23, 2014 1:04 am

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

A new drug in phase II

I haven't heard of this before, and didn't see it on the company's website.

A Study in Multiple Sclerosis Patients to Determine the Safety of Different Doses of A4I Compared to Placebo and Their Effects on Multiple Sclerosis Lesions

This study is not yet open for patient recruitment.

Verified by Hoffmann-La Roche June 2006
Sponsored by: Hoffmann-La Roche
Information provided by: Hoffmann-La Roche

The purpose of this study is to determine the safety and ...
Read more : A new drug in phase II | Views : 1478 | Replies : 0 | Forum : Drug Pipeline

IVI research

It's good that researchers are starting to understand how different treatments work.

<shortened url>
Read more : IVI research | Views : 866 | Replies : 0 | Forum : General Discussion

Stem cell story

Stem cell op helps woman to stand again

A WOMAN confined to a wheelchair for the past five years has told of the miracle moment she stood up after revolutionary stem-cell treatment.
Julia Sandeman, who suffers from multiple sclerosis, paid £13,500 for the make-or-break operation in a Dutch clinic.

After the procedure she regained sensation in her limbs and is now able to balance upright in a therapy pool, sparking fresh hope she will ...
Read more : Stem cell story | Views : 1452 | Replies : 0 | Forum : Stem Cells


Avigen, Inc. today announced it was given approval from the U.S. Food and Drug Administration to commence its initial clinical trial of AV650. AV650 is a New Chemical Entity (NCE) in the U.S. The initial clinical trial will be a Phase I study to assess the safety and pharmacokinetic profile, as well as AV650's lack of sedation in normal volunteers. Avigen plans to initiate clinical development in the second half of 2006.
AV650 is being ...
Read more : AV650 | Views : 1034 | Replies : 0 | Forum : Drug Pipeline

Rituxan for RA

Rituxan is currently in MS trials (for PP, SP and RR).

It was approved earlier this year for Rheumatoid Arthritis.

Phase III results for RA look good - like MS, RA was considered a T cell mediated disease but B cells also looks as if they play a role.

Let's hope that the Rituxan trials for MS show similar good results.

Ian ... PR_133.htm
Read more : Rituxan for RA | Views : 1156 | Replies : 0 | Forum : Drug Pipeline

The sun and immunosupressive drugs

Like we needed more stuff to worry about. I saw a news story on my local news channel about how people taking immune system supressive drugs should be extra careful with exposure to the sun. Supposedly we are at greater risk for skin cancer. Just an FYI to everyone to use lots of sunblock this summer. 8)
Read more : The sun and immunosupressive drugs | Views : 1176 | Replies : 6 | Forum : General Discussion

What drug to take?

The following note was written by Art Mellor of The Boston Cure Project. It is something that each and every MS patient should read before deciding what drug he/she may use.



Is This the Drug for Me?
By Art Mellor
Dec, 2005

This article is the third in a series that discusses things to consider when evaluating trial results for a new treatment. In this installment, I'd like to cover a set of ...
Read more : What drug to take? | Views : 1145 | Replies : 10 | Forum : General Discussion

Paralysed rat

This is the NMSS article on the paralysed rat research that I posted earlier this week.

Ian ... June22.asp
Read more : Paralysed rat | Views : 831 | Replies : 0 | Forum : General Discussion

Vit D - one for Jimmylegs


Research on Vit D. Now I don't want to hear anymore about bloody Vit D.

Jimmylegs is off to Western Australia for six months where temperatures can hit 110F. Have a nice time.

Ian ... nd_ms.html
Read more : Vit D - one for Jimmylegs | Views : 1237 | Replies : 4 | Forum : General Discussion


Login  •  Register


Total posts 221695 • Total topics 23016 • Total members 14540

Contact us | Terms of Service